Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Shattuck Labs (STTK) Cash & Equivalents (2019 - 2025)

Historic Cash & Equivalents for Shattuck Labs (STTK) over the last 7 years, with Q3 2025 value amounting to $42.5 million.

  • Shattuck Labs' Cash & Equivalents fell 292.27% to $42.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.5 million, marking a year-over-year decrease of 292.27%. This contributed to the annual value of $57.4 million for FY2024, which is 5431.92% down from last year.
  • Latest data reveals that Shattuck Labs reported Cash & Equivalents of $42.5 million as of Q3 2025, which was down 292.27% from $50.5 million recorded in Q2 2025.
  • Shattuck Labs' Cash & Equivalents' 5-year high stood at $125.6 million during Q4 2023, with a 5-year trough of $37.9 million in Q2 2022.
  • Its 5-year average for Cash & Equivalents is $64.2 million, with a median of $60.7 million in 2024.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 5621.66% in 2022, then surged by 16515.12% in 2023.
  • Shattuck Labs' Cash & Equivalents (Quarter) stood at $92.3 million in 2021, then plummeted by 48.65% to $47.4 million in 2022, then soared by 165.15% to $125.6 million in 2023, then crashed by 54.32% to $57.4 million in 2024, then dropped by 25.86% to $42.5 million in 2025.
  • Its Cash & Equivalents was $42.5 million in Q3 2025, compared to $50.5 million in Q2 2025 and $60.9 million in Q1 2025.